Balchem Corporation (BCPC) - Total Liabilities
Based on the latest financial reports, Balchem Corporation (BCPC) has total liabilities worth $450.15 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BCPC cash flow metrics to assess how effectively this company generates cash.
Balchem Corporation - Total Liabilities Trend (1985–2025)
This chart illustrates how Balchem Corporation's total liabilities have evolved over time, based on quarterly financial data. Check Balchem Corporation asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Balchem Corporation Competitors by Total Liabilities
The table below lists competitors of Balchem Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IPG Photonics Corporation
NASDAQ:IPGP
|
USA | $296.15 Million |
|
Paylocity Holdng
NASDAQ:PCTY
|
USA | $5.87 Billion |
|
SmartSens Technology (Shanghai) Co. Ltd. A
SHG:688213
|
China | CN¥5.55 Billion |
|
Beijing Shougang Co Ltd
SHE:000959
|
China | CN¥74.10 Billion |
|
Sichuan Yahua Industrial Group Co Ltd
SHE:002497
|
China | CN¥3.37 Billion |
|
Brunswick Corporation
NYSE:BC
|
USA | $3.69 Billion |
|
Ralliant Corporation Common Stock
NYSE:RAL
|
USA | $2.30 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Balchem Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Balchem Corporation worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Balchem Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Balchem Corporation (1985–2025)
The table below shows the annual total liabilities of Balchem Corporation from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $450.15 Million | +5.80% |
| 2024-12-31 | $425.46 Million | -21.68% |
| 2023-12-31 | $543.23 Million | -20.84% |
| 2022-12-31 | $686.23 Million | +112.91% |
| 2021-12-31 | $322.31 Million | -4.53% |
| 2020-12-31 | $337.61 Million | -18.06% |
| 2019-12-31 | $412.01 Million | +42.20% |
| 2018-12-31 | $289.74 Million | -16.44% |
| 2017-12-31 | $346.75 Million | -18.91% |
| 2016-12-31 | $427.59 Million | +2.41% |
| 2015-12-31 | $417.52 Million | -11.05% |
| 2014-12-31 | $469.37 Million | +931.27% |
| 2013-12-31 | $45.51 Million | +15.13% |
| 2012-12-31 | $39.53 Million | -0.44% |
| 2011-12-31 | $39.71 Million | -3.52% |
| 2010-12-31 | $41.16 Million | +1.20% |
| 2009-12-31 | $40.67 Million | +1.76% |
| 2008-12-31 | $39.97 Million | -34.85% |
| 2007-12-31 | $61.34 Million | +261.46% |
| 2006-12-31 | $16.97 Million | +19.45% |
| 2005-12-31 | $14.21 Million | +39.69% |
| 2004-12-31 | $10.17 Million | -40.61% |
| 2003-12-31 | $17.12 Million | -14.50% |
| 2002-12-31 | $20.03 Million | +4.62% |
| 2001-12-31 | $19.14 Million | +425.67% |
| 2000-12-31 | $3.64 Million | -11.17% |
| 1999-12-31 | $4.10 Million | -39.71% |
| 1998-12-31 | $6.80 Million | +28.30% |
| 1997-12-31 | $5.30 Million | -7.02% |
| 1996-12-31 | $5.70 Million | -17.39% |
| 1995-12-31 | $6.90 Million | +7.81% |
| 1994-12-31 | $6.40 Million | +56.10% |
| 1993-12-31 | $4.10 Million | +32.26% |
| 1992-12-31 | $3.10 Million | -3.13% |
| 1991-12-31 | $3.20 Million | +39.13% |
| 1990-12-31 | $2.30 Million | -4.17% |
| 1989-12-31 | $2.40 Million | -20.00% |
| 1988-12-31 | $3.00 Million | +25.00% |
| 1987-12-31 | $2.40 Million | +41.18% |
| 1986-12-31 | $1.70 Million | -5.56% |
| 1985-12-31 | $1.80 Million | -- |
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment… Read more